Sign up to save your podcasts
Or
Share Nano-pulse Stimulation - Clearing Away Damaged, Diseased, or Aged Cells
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nano-pulse Stimulation - Clearing Away Damaged, Diseased, or Aged Cells
In this episode of The OncoZine Brief Peter Hofland interviews Darrin Uecker and Richard Nuccitelli of Pulse Biosciences.
The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology delivers ultra-short nanosecond pulses to stimulate cellular responses in targeted tissue. These pulses induce cells to die in a natural way.
Preclinical studies indicate that NPS can stimulate the adaptive immune response, commonly known as immunogenic cell death. The new technology thus engages the immune system to clear away damaged, diseased, or aged cells and recruit cancer-attacking T cells to the tumor site.
Darrin Uecker and Richard Nuccitelli explain how this new technology works, its history and how this may benefit patients.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology delivers ultra-short nanosecond pulses to stimulate cellular responses in targeted tissue. These pulses induce cells to die in a natural way.
Preclinical studies indicate that NPS can stimulate the adaptive immune response, commonly known as immunogenic cell death. The new technology thus engages the immune system to clear away damaged, diseased, or aged cells and recruit cancer-attacking T cells to the tumor site.
Darrin Uecker and Richard Nuccitelli explain how this new technology works, its history and how this may benefit patients.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
View all episodes
By Peter Hofland
3
22 ratings
In this episode of The OncoZine Brief Peter Hofland interviews Darrin Uecker and Richard Nuccitelli of Pulse Biosciences.
The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology delivers ultra-short nanosecond pulses to stimulate cellular responses in targeted tissue. These pulses induce cells to die in a natural way.
Preclinical studies indicate that NPS can stimulate the adaptive immune response, commonly known as immunogenic cell death. The new technology thus engages the immune system to clear away damaged, diseased, or aged cells and recruit cancer-attacking T cells to the tumor site.
Darrin Uecker and Richard Nuccitelli explain how this new technology works, its history and how this may benefit patients.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology delivers ultra-short nanosecond pulses to stimulate cellular responses in targeted tissue. These pulses induce cells to die in a natural way.
Preclinical studies indicate that NPS can stimulate the adaptive immune response, commonly known as immunogenic cell death. The new technology thus engages the immune system to clear away damaged, diseased, or aged cells and recruit cancer-attacking T cells to the tumor site.
Darrin Uecker and Richard Nuccitelli explain how this new technology works, its history and how this may benefit patients.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.